Angelica Torres-Berrio, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 4 | 2020 | 3750 | 0.880 |
Why?
|
| Stress, Psychological | 6 | 2021 | 4245 | 0.880 |
Why?
|
| Prefrontal Cortex | 5 | 2020 | 2147 | 0.860 |
Why?
|
| Opioid Peptides | 1 | 2018 | 42 | 0.650 |
Why?
|
| Limbic System | 1 | 2018 | 424 | 0.540 |
Why?
|
| Pyramidal Cells | 2 | 2020 | 363 | 0.510 |
Why?
|
| Behavior, Animal | 2 | 2018 | 1880 | 0.390 |
Why?
|
| Depressive Disorder, Major | 3 | 2020 | 4635 | 0.390 |
Why?
|
| Memory Disorders | 1 | 2018 | 1186 | 0.390 |
Why?
|
| Receptors, Cell Surface | 2 | 2020 | 2865 | 0.380 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 2850 | 0.360 |
Why?
|
| Learning | 1 | 2018 | 1710 | 0.340 |
Why?
|
| Social Behavior | 3 | 2020 | 1126 | 0.310 |
Why?
|
| Hippocampus | 2 | 2020 | 3672 | 0.290 |
Why?
|
| Nucleus Accumbens | 2 | 2021 | 366 | 0.280 |
Why?
|
| Depressive Disorder | 1 | 2019 | 3744 | 0.280 |
Why?
|
| Depression | 2 | 2020 | 7760 | 0.230 |
Why?
|
| Down-Regulation | 2 | 2020 | 3000 | 0.210 |
Why?
|
| Axons | 2 | 2020 | 1685 | 0.190 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2020 | 107 | 0.180 |
Why?
|
| Maze Learning | 2 | 2018 | 478 | 0.180 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2021 | 291 | 0.170 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2021 | 475 | 0.160 |
Why?
|
| Histone Demethylases | 1 | 2021 | 321 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17439 | 0.160 |
Why?
|
| Tetrodotoxin | 1 | 2018 | 259 | 0.150 |
Why?
|
| Altruism | 1 | 2018 | 204 | 0.140 |
Why?
|
| Space Perception | 1 | 2018 | 474 | 0.130 |
Why?
|
| Cues | 1 | 2020 | 874 | 0.130 |
Why?
|
| Ketamine | 1 | 2020 | 501 | 0.120 |
Why?
|
| Animals | 9 | 2021 | 168660 | 0.120 |
Why?
|
| Epigenomics | 1 | 2019 | 903 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 2123 | 0.110 |
Why?
|
| Neurons | 2 | 2021 | 9336 | 0.100 |
Why?
|
| Mice | 6 | 2021 | 81154 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2019 | 4221 | 0.090 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 2837 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8300 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2019 | 4286 | 0.070 |
Why?
|
| Male | 7 | 2021 | 349776 | 0.060 |
Why?
|
| Rats | 1 | 2018 | 24250 | 0.050 |
Why?
|
| Cognition | 1 | 2018 | 6759 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2016 | 13028 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 12259 | 0.050 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2020 | 67 | 0.050 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2020 | 92 | 0.050 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 182 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16674 | 0.040 |
Why?
|
| F-Box Proteins | 1 | 2021 | 196 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2020 | 377 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 21824 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8035 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 671 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2020 | 598 | 0.040 |
Why?
|
| Interneurons | 1 | 2020 | 577 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2020 | 1176 | 0.030 |
Why?
|
| Humans | 4 | 2020 | 743811 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1656 | 0.030 |
Why?
|
| Histones | 1 | 2021 | 2598 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2916 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 3463 | 0.020 |
Why?
|
| Attention | 1 | 2017 | 2393 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 12066 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 29777 | 0.010 |
Why?
|